Please check your internet connection and try again.
# Potassium Chloride
## Overview
Potassium chloride (KCL) is an essential electrolyte used to treat or prevent hypokalemia. It is available in oral and intravenous formulations.
## Primary Indications
* Treatment of hypokalemia.
* Prevention of hypokalemia in patients at risk.
## Adult Dosing
* **Oral:**
* **Treatment of hypokalemia:** Typically 20-80 mEq per day in 2-4 divided doses. Higher doses may be required for severe hypokalemia, up to 120 mEq per day.
* **Prevention of hypokalemia:** Typically 20-40 mEq per day in 1-2 divided doses.
* **Intravenous (IV):**
* **Treatment of hypokalemia:** Dosing is individualized based on serum potassium levels and clinical status. Typically infused at a rate no faster than 10-20 mEq/hour. Maximum infusion rates are often limited to 20 mEq/hour to reduce the risk of cardiac arrhythmias. Total daily dose is usually 80-120 mEq, but can be higher in severe cases.
* **Peripheral IV:** Concentration should not exceed 40 mEq/L.
* **Central IV:** Concentration may be higher, but follow institutional guidelines.
## Pediatric Dosing
* **Oral:**
* **Treatment of hypokalemia:** 2-5 mEq/kg/day in divided doses. Maximum daily dose generally 40 mEq.
* **Prevention of hypokalemia:** 1-2 mEq/kg/day. Maximum daily dose generally 20 mEq.
* **Intravenous (IV):**
* Dosing is highly individualized based on serum potassium and clinical condition.
* Maximum infusion rate generally 0.5-1 mEq/kg/hour, not to exceed 20 mEq/hour, to avoid hyperkalemia and cardiac effects.
* Maximum concentration for peripheral infusion typically 40 mEq/L. Central line infusion may allow higher concentrations, per institutional policy.
## Dose Adjustments
* **Renal Impairment:** Use with extreme caution. Potassium accumulation can lead to hyperkalemia. Dose reductions are necessary.
* **Adrenal Insufficiency:** May potentiate hyperkalemia.
## Contraindications
* Severe renal impairment.
* Hyperkalemia.
* Conditions which may lead to the development of hyperkalemia (e.g., untreated Addison's disease, severe tissue trauma, severe burns, certain enzyme deficiencies).
* Known hypersensitivity to potassium chloride.
## Adverse Effects
* **Common:** Nausea, vomiting, diarrhea, abdominal discomfort, flatulence.
* **Serious:** Hyperkalemia (can be life-threatening), cardiac arrhythmias, cardiac arrest, ECG changes (peaked T waves, flattened P waves, prolonged QRS, QT interval), hypotension, ileus.
## Key Drug Interactions
* **ACE Inhibitors/ARBs/Potassium-Sparing Diuretics (e.g., spironolactone, amiloride):** Increased risk of hyperkalemia.
* **NSAIDs:** Can decrease renal excretion of potassium, increasing risk of hyperkalemia.
* **Heparin:** May cause hyperkalemia by inhibiting aldosterone production.
* **Digoxin:** Hyperkalemia can increase digoxin toxicity. Hypokalemia can decrease digoxin toxicity but can also cause arrhythmias.
## Monitoring
* **Serum potassium levels:** Frequently, especially during IV therapy and dose adjustments.
* **Renal function:** Baseline and periodically.
* **ECG:** For signs of hyperkalemia, especially with rapid IV infusion or in patients with cardiac history.
* **Fluid balance and urine output.**
## Clinical Pearls
* Oral potassium chloride solutions can be very unpalatable; consider flavored preparations or mixing with juice.
* Rapid IV infusion of potassium chloride can cause pain at the injection site and is associated with a higher risk of serious adverse events, including cardiac arrest. Always dilute and infuse slowly.
* Never administer potassium chloride as an IV bolus injection.
* Hypokalemia can be exacerbated by diuretics, vomiting, diarrhea, and inadequate dietary intake.
* Be aware of potassium content in other medications and intravenous fluids.
***
*Disclaimer: This information is intended for healthcare professionals. Always consult the most current prescribing information and institutional protocols for definitive guidance. Dosing may vary based on individual patient factors and clinical circumstances.*
